drugset
drugset / Trial / NCT06418620

A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants

NCT06418620 ↗

Phase 1 Completed 9 enrolled Sanofi
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of food on the bioavailability of venglustat and to assess the relative bioavailability of venglustat tablet swallowed whole with water versus a tablet chewed and then swallowed without water. Also, to evaluate the safety and tolerability of a single dose tablet of venglustat under fed (swallowed whole) and fasted (swallowed whole or chewed) conditions in healthy adult participants. The maximum duration for participants from screening is up to 63 days.

Timeline

Start
2020-06-18
Primary completion
2020-08-07
Completion
2020-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Venglustat Small molecule — Oral

Indications

No indication recorded.